Erin P Madeen Selected Research

Carcinogens

1/2022	Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.
7/2013	Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erin P Madeen Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 07/2013
2	Carcinogenesis 01/2017 - 07/2013
1	Inflammation (Inflammations) 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2013

Drug/Important Bio-Agent (IBA)

3	dibenzo(a,l)pyreneIBA 01/2022 - 07/2013
2	CarcinogensIBA 01/2022 - 07/2013
2	Dihydrotachysterol (AT 10)IBA 01/2017 - 07/2013
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022
1	CytokinesIBA 09/2021
1	ChemokinesIBA 09/2021
1	Phosphotransferases (Kinase)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	RacivirIBA 01/2018
1	sulforaphaneIBA 07/2013
1	indole-3-carbinolIBA 07/2013